Ozempic vs Wegovy is one of the most common questions in the GLP-1 world, and for good reason. The two are the same drug, yet they are sold under different names, approved for different uses, and priced differently. That overlap creates a lot of confusion.
This guide breaks down exactly how Ozempic and Wegovy compare, what the clinical research shows about each, and which differences actually matter when you are weighing your options. The short version: same molecule, different packaging and purpose.
Ozempic vs Wegovy: The Same Drug, Different Jobs
Both Ozempic and Wegovy contain the same active ingredient, semaglutide, a GLP-1 receptor agonist that lowers appetite and slows how fast the stomach empties. As GoodRx outlines, the real difference is what each one is FDA approved to treat.
Ozempic is approved for type 2 diabetes, and to lower cardiovascular risk in adults who have type 2 diabetes and heart disease. Wegovy is approved for chronic weight management, and in 2024 it became the first weight-management drug approved to reduce the risk of major cardiovascular events in adults with overweight or obesity.
So biologically they do the same thing. The label, the dose, and the intended patient are what differ.
Dose Differences, and Why They Matter
The clearest difference between Ozempic and Wegovy is the dose.
Ozempic tops out at 2.0 mg once weekly. Wegovy goes higher, up to 2.4 mg once weekly, and in 2026 the FDA approved an even higher-dose version, Wegovy HD, at 7.2 mg.
Semaglutide works in a dose-response way, meaning more drug within the studied range generally produces more appetite suppression and more weight loss. That is why the higher Wegovy doses tend to drive more weight loss than Ozempic’s diabetes doses. We cover this dose logic further in our microdosing guide.
Ozempic vs Wegovy for Weight Loss
Here is what the trials actually show.
Wegovy at 2.4 mg produced about 15% average body weight loss over 68 weeks in the STEP 1 trial. The newer 7.2 mg dose reached around 21% in the STEP UP trial.
Ozempic, used at its diabetes doses up to 2.0 mg, produces less, commonly cited in the 8% to 14% range, because it is dosed lower and was studied primarily for blood sugar rather than weight.
So if weight loss is the main goal, Wegovy is the version designed and approved for it. That said, the medication is only half the equation. What you eat and whether you train decides how much of the loss is fat versus muscle, which we cover in what to eat on a GLP-1 and Ozempic muscle loss.
Ozempic vs Wegovy at a Glance
| Feature | Ozempic | Wegovy |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| FDA approved for | Type 2 diabetes; heart risk in diabetes | Weight management; heart risk in obesity |
| Maximum dose | 2.0 mg per week | 2.4 mg per week (7.2 mg “HD” in 2026) |
| Average weight loss in trials | About 8% to 14% (diabetes doses) | About 15% (2.4 mg), about 21% (7.2 mg) |
| Available forms | Injection only | Injection plus an oral tablet (2025) |
| List price per month, no insurance | About $935 to $1,027 | About $1,349 |
Cost and Insurance
Cost is where the two diverge most for real patients.
Without insurance, Ozempic lists around $935 to $1,027 per month, while Wegovy lists around $1,349. Ozempic is also more often covered by insurance because it treats diabetes, a long-covered condition. Wegovy coverage for obesity is inconsistent and usually requires prior authorization, which can make it more expensive out of pocket even though it is the same drug.
In 2026, Novo Nordisk introduced self-pay subscription pricing for Wegovy through select telehealth providers, roughly $249 to $329 per month depending on how long a plan you commit to.
For the full breakdown of every savings option, see our Ozempic cost without insurance guide.
Forms: Injection vs Pill
Ozempic is available only as a once-weekly injection. Wegovy is available as an injection and, since 2025, as an oral tablet, which gives people who dislike needles another option.
The oral and injectable forms are not identical in how they are absorbed, so which one fits is worth discussing with a prescriber.
Can You Switch, or Take Both?
Two questions come up constantly, and both have clear answers.
You cannot take Ozempic and Wegovy together. They are the same drug, so combining them means double-dosing semaglutide, which is unsafe.
Switching between them is also not a simple swap. Because they are dosed differently, moving from Ozempic to Wegovy, or the other way, involves a titration plan set by your prescriber, not a one-to-one trade.
What Ozempic and Wegovy Share: Protecting Your Muscle
Whichever version you take, the same trade-off applies. Rapid weight loss on semaglutide includes lean mass, not just fat, and research suggests a meaningful share of the weight lost on GLP-1 medications can come from muscle.
That is why the smartest thing you can do on either drug is protect muscle with adequate protein and resistance training. We break down the exact targets in our Ozempic muscle loss guide. It is the difference between losing weight and losing the right weight.
The Bottom Line
Ozempic and Wegovy are the same medicine, semaglutide, approved for different jobs. Ozempic is for diabetes, and Wegovy is for weight management at a higher dose. If weight loss is your primary goal, Wegovy is the version built for it, though it usually costs more and is harder to get covered. If you have type 2 diabetes, Ozempic is the approved choice and is more likely to be covered.
Either way, the medication is a tool, not the whole plan. Pair it with the right nutrition and training, and make the decision with a qualified healthcare provider. For how the GLP-1 landscape compares beyond semaglutide, see our Ozempic vs Mounjaro guide and peptides for weight loss.